This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Chronic Sinusitis
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This study allows continued access to the Sinexus Intranasal Splint while a marketing application is being prepared. This study will generate additional performance, reimbursement and safety data for the steroid-eluting Sinexus Intranasal Splint when used following Functional Endoscopic Sinus Surgery (FESS) in patients with chronic sinusitis (CS).

Provided treatments

  • Device: Steroid-Eluting Sinexus Intranasal Splint
Tris trial is registered with FDA with number: NCT00912405. The sponsor of the trial is Intersect ENT and it is looking for 50 volunteers for the current phase.
Official trial title:
A Clinical Evaluation of the Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis